Product Introduction
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is a chemical compound. Its molecular structure contains three iodine atoms. The high atomic number of iodine gives it strong X-ray absorption ability, which can significantly improve image contrast and help more clearly observe tissues, blood vessels and diseased areas in the body. It is widely used in tumors, Imaging tests for cardiovascular and neurological diseases.
Product Features
Radioabsorbability
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide contains a triiodo group, and the atomic number of each iodine atom is 53 , capable of significantly enhancing image contrast in X-ray or CT scans. Compared with traditional iodine contrast agents (such as sodium iodide), the radioactive absorption efficiency of this product is increased by about 30%, making the imaging resolution clearer and especially suitable for high-precision imaging of tumors, blood vessels and soft tissues.
Biocompatibility
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide has strong biocompatibility and is compatible with human blood and tissue. There are fewer interactions, with about 75% of the compounds not binding to plasma proteins, while the protein binding rate of traditional contrast agents is usually 85%-95%. This suggests its ability to reduce interactions with blood components, thereby reducing the risk of allergic reactions and the production of toxic metabolites.
Stability
The chemical structure of 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide has extremely high stability. After 12 months of When stored at room temperature, the loss of its active ingredients is less than 5%, which is much lower than that of general radioactive contrast agents (usually 10%).
Targeting
The acetamido and dihydroxypropyl groups of the compound can specifically bind to biomolecules and enhance targeting capabilities. The tissue positioning efficiency of 5-acetamido-triiodoisophthalamide is as high as 85%, which is significantly improved compared to traditional contrast agents (about 60%), and can more accurately focus on specific disease areas, such as tumor cells. or areas of inflammation, reducing the impact on healthy tissue.
